Gastrointestinal behavior of posaconazol in healthy human volunteers
Latest Information Update: 21 Aug 2019
Price :
$35 *
At a glance
- Drugs Posaconazole (Primary)
- Indications Aspergillosis; Candidiasis; Chagas disease; Invasive bronchopulmonary aspergillosis; Mycoses; Oropharyngeal candidiasis
- Focus Pharmacokinetics
- 21 Aug 2019 The trial has been completed in Belgium. According to the European Clinical Trials Database.
- 29 Sep 2014 New trial record